Pages that link to "Q71165481"
Jump to navigation
Jump to search
The following pages link to Disposition of mitoxantrone in patients (Q71165481):
Displaying 12 items.
- A Physiologically Based Pharmacokinetic Model of Mitoxantrone in Mice and Scale-up to Humans: a Semi-Mechanistic Model Incorporating DNA and Protein Binding (Q35888381) (← links)
- Pharmacokinetics of mitoxantrone in cancer patients treated by high-dose chemotherapy and autologous bone marrow transplantation (Q35993673) (← links)
- Mass balance studies, with a focus on anticancer drugs. (Q36375326) (← links)
- Pharmacokinetics and metabolism of mitoxantrone. A review (Q37920867) (← links)
- Pharmacology of mitoxantrone: mode of action and pharmacokinetics. (Q54457003) (← links)
- Phase I/II pharmacokinetic study of mitoxantrone by continuous venous infusion in patients with solid tumours and lymphoproliferative diseases (Q67900950) (← links)
- Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration (Q68100402) (← links)
- Effectiveness of mitoxantrone on the proliferation of cell cultures derived from malignant mesenchymal tumors of human origin (Q68291379) (← links)
- Comparative in vitro toxicity of mitoxantrone and adriamycin in human granulocyte-macrophage progenitor cells (Q69206342) (← links)
- High-performance liquid chromatographic determination of mitoxantrone in plasma utilizing non-bonded silica gel for solid-phase isolation to reduce adsorptive losses on glass during sample preparation (Q69341058) (← links)
- Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy (Q69615446) (← links)
- Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography (Q93616788) (← links)